CFD-ji (pogodbe za razliko) so kompleksni instrumenti in so zaradi uporabe finančnega vzvoda povezani z visokim tveganjem za hitro izgubo denarja. 84% vlagateljev izgubi denar, ko trguje s CFD-ji pri tem ponudniku. Razmisliti morate, ali razumete, kako delujejo CFD-ji in ali si lahko privoščite tako visoko tveganje za izgubo svojega denarja.

Scan to Download iOS&Android APP

Trgovina Eagle Pharm - EGRX CFD

-
0%
  • Povzetek
  • Zgodovinski podatki
  • Dogodki
  • Izkaz poslovnega izida
  • Bilanca stanja
  • Denarni tok
  • Lastništvo
Pogoji trgovanja
Razmik -
Nočna pristojbina za nakup

Long position overnight fee


Margin. Your investment $1,000.00
Nočna pristojbina -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Pojdi na platformo
-0.030779%
Nočna pristojbina za prodajo

Short position overnight fee


Margin. Your investment $1,000.00
Nočna pristojbina -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Pojdi na platformo
-0.013666%
Čas nočne pristojbine 22:00 (UTC)
Min. tržena količina 1
Valuta USD
Kritje 20%
Borza United States of America
Provizija na trgovanje 0%

*Information provided by Capital.com

Ključni statistični podatki
Predhodno. Zapri* N/A
Odpri* N/A
Enoletna sprememba* N/A
Dnevni razpon* N/A
Razpon 52 wk 24.35-53.78
Povprečni obseg (10 dni) 128.04K
Povprečni obseg (3 meseci) 3.10M
Tržna kapitalizacija 436.16M
Razmerje P/E 20.24
Število delnic v obtoku 13.02M
Prihodki 298.23M
EPS 1.66
Dividenda (donosnost v %) N/A
Beta 0.89
Datum naslednjega zaslužka Mar 6, 2023

Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Zapiranje Change Change (%) Odpiranje High Low

Eagle Pharm Events

Time (UTC) Country Event
No events scheduled
View all events
  • Letni
  • Četrtletno
2016 2017 2018 2019 2020 2021
Skupni prihodki 189.482 236.707 213.312 195.892 187.802 171.546
Prihodki 189.482 236.707 213.312 195.892 187.802 171.546
Celotni stroški prihodkov 55.306 57.186 61.916 60.897 45.465 42.18
Bruto dobiček 134.176 179.521 151.396 134.995 142.337 129.366
Celotni odhodki iz poslovanja 136.131 162.717 176.696 174.077 154.848 168.777
Celotna prodaja/splošni/upravni stroški Odhodki 52.313 71.416 60.509 76.37 78.598 75.322
Raziskave in razvoj 30.262 32.607 44.419 36.81 30.785 51.275
Nenavadni odhodki (prihodki) -1.75 8.885 10.615 0 0
Prihodki iz poslovanja 53.351 73.99 36.616 21.815 32.954 2.769
Prihodki (odhodki) od obresti, neto Neoperativni 0.076 -1.045 -2.578 -0.517 -2.015 -7.275
Drugo, neto 0 0.7 -8.262 -0.042
Čisti dobiček pred obdavčitvijo 53.427 72.945 34.038 21.998 22.677 -4.548
Čisti dobiček po davkih 81.453 55.343 31.903 14.313 11.989 -8.627
Čisti dobiček pred dodatnimi postavkami 81.453 55.343 31.903 14.313 11.989 -8.627
Čisti dobiček 81.453 51.943 31.903 14.313 11.989 -8.627
Total Adjustments to Net Income 0
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk 81.453 55.343 31.903 14.313 11.989 -8.627
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami 81.453 51.943 31.903 14.313 11.989 -8.627
Popravljen čisti dobiček 81.453 51.943 31.903 14.313 11.989 -8.627
Popravljene ponderirane povprečne delnice 16.4341 15.9082 15.2787 14.1387 13.7714 13.0511
Popravljen dobiček na delnico brez upoštevanja izrednih postavk 4.95634 3.4789 2.08808 1.01233 0.87057 -0.66102
Popravljen normalizirani dobiček na enoto čistega dobička 4.88712 3.90264 2.73926 1.01233 0.87057 -0.66102
Other Operating Expenses, Total -7.377 -0.763 0 0
Skupaj izredne postavke -3.4
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Skupni prihodki 41.249 48.124 39.853 42.32 115.874
Prihodki 41.249 48.124 39.853 42.32 115.874
Celotni stroški prihodkov 10.855 10.757 8.259 12.309 27.755
Bruto dobiček 30.394 37.367 31.594 30.011 88.119
Celotni odhodki iz poslovanja 45.022 37.304 50.03 36.421 56.045
Celotna prodaja/splošni/upravni stroški Odhodki 19.879 16.636 18.482 20.325 22.182
Raziskave in razvoj 14.288 9.911 23.289 3.787 6.108
Prihodki iz poslovanja -3.773 10.82 -10.177 5.899 59.829
Prihodki (odhodki) od obresti, neto Neoperativni 5.213 -5.459 -2.499 -4.53 -2.712
Drugo, neto -0.1 0.187 0.016 -0.145 0.543
Čisti dobiček pred obdavčitvijo 1.34 5.548 -12.66 1.224 57.66
Čisti dobiček po davkih -0.421 3.612 -5.622 -6.196 44.058
Čisti dobiček pred dodatnimi postavkami -0.421 3.612 -5.622 -6.196 44.058
Čisti dobiček -0.421 3.612 -5.622 -6.196 44.058
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk -0.421 3.612 -5.622 -6.196 44.058
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami -0.421 3.612 -5.622 -6.196 44.058
Popravljen čisti dobiček -0.421 3.612 -5.622 -6.196 44.058
Popravljene ponderirane povprečne delnice 13.0694 13.2622 13.0773 12.8948 12.9068
Popravljen dobiček na delnico brez upoštevanja izrednih postavk -0.03221 0.27235 -0.42991 -0.4805 3.41355
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Popravljen normalizirani dobiček na enoto čistega dobička -0.03221 0.27235 -0.42991 -0.4805 3.41355
  • Letni
  • Četrtletno
2016 2017 2018 2019 2020 2021
Kratkoročna sredstva skupaj 109.11 188.697 163.844 179.449 166.065 172.606
Denarna sredstva in kratkoročne naložbe 52.82 114.657 78.791 109.775 103.155 97.659
Denarna sredstva in ustrezniki 52.82 114.657 78.791 109.775 103.155 97.659
Celotne terjatve, neto 42.194 53.821 66.486 48.004 51.117 41.149
Accounts Receivable - Trade, Net 42.194 53.821 66.486 48.004 51.117 41.149
Total Inventory 2.739 5.118 8.304 6.566 8.075 21.908
Prepaid Expenses 11.357 15.101 10.263 15.104 3.718 11.89
Total Assets 214.32 270.06 238.603 254.554 253.19 253.732
Property/Plant/Equipment, Total - Net 3.316 6.82 2.397 5.918 2.077 1.636
Property/Plant/Equipment, Total - Gross 4.822 9.258 5.744 10.237 7.268 7.591
Accumulated Depreciation, Total -1.506 -2.438 -3.347 -4.319 -5.191 -5.955
Goodwill, Net 39.743 39.743 39.743 39.743 39.743 39.743
Intangibles, Net 33.372 23.322 18.103 15.583 12.917 10.671
Other Long Term Assets, Total 28.779 11.478 14.516 13.861 32.388 29.076
Total Current Liabilities 40.965 47.302 39.686 38.823 38.085 74.376
Accounts Payable 15.728 27.036 9.917 5.462 6.268 16.431
Accrued Expenses 23.549 15.391 23.519 28.361 23.817 32.338
Notes Payable/Short Term Debt 0 0 0 0 0 0
Other Current Liabilities, Total 1.688
Total Liabilities 63.094 90.916 77.841 75.38 67.179 77.279
Total Long Term Debt 0 42.905 38.155 33.557 25.135 0
Other Liabilities, Total 22.129 0.709 0 3 3.959 2.903
Total Equity 151.226 179.144 160.762 179.174 186.011 176.453
Common Stock 0.016 0.016 0.017 0.017 0.017 0.017
Additional Paid-In Capital 213.872 233.639 256.458 278.518 305.403 325.779
Retained Earnings (Accumulated Deficit) -25.659 26.284 58.187 72.5 84.489 75.862
Treasury Stock - Common -37.003 -80.795 -153.9 -171.861 -203.898 -225.111
Total Liabilities & Shareholders’ Equity 214.32 270.06 238.603 254.554 253.19 253.732
Total Common Shares Outstanding 15.324 14.8477 13.914 13.6302 13.057 12.7914
Current Port. of LT Debt/Capital Leases 4.875 6.25 5 8 25.607
Long Term Debt 42.905 38.155 33.557 25.135 0
Redeemable Preferred Stock 0 0 0 0
Other Equity, Total -0.094
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Kratkoročna sredstva skupaj 163.986 175.504 171.694 172.606 240.166
Denarna sredstva in kratkoročne naložbe 105.229 108.717 99.741 97.659 69.522
Denarna sredstva in ustrezniki 105.229 108.717 99.741 97.659 69.522
Celotne terjatve, neto 44.868 52.659 47.081 41.149 130.858
Accounts Receivable - Trade, Net 44.868 52.659 45.335 41.149 130.858
Total Inventory 6.862 8.294 9.315 21.908 24.818
Prepaid Expenses 7.027 5.834 15.557 11.89 14.968
Total Assets 259.968 264.242 256.261 253.732 320.165
Property/Plant/Equipment, Total - Net 2.27 1.967 1.775 1.636 1.627
Property/Plant/Equipment, Total - Gross 7.652 7.537 7.542 7.591 7.759
Accumulated Depreciation, Total -5.382 -5.57 -5.767 -5.955 -6.132
Goodwill, Net 39.743 39.743 39.743 39.743 39.743
Intangibles, Net 12.211 11.505 10.799 10.671 9.94
Other Long Term Assets, Total 41.758 35.523 32.25 29.076 28.689
Total Current Liabilities 41.973 44.664 48.431 74.376 101.642
Accounts Payable 12.559 11.136 12.717 16.431 14.509
Accrued Expenses 21.414 25.528 27.714 32.338 63.408
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 8 8 8 25.607 23.725
Total Liabilities 68.89 69.395 70.968 77.279 104.205
Total Long Term Debt 23.253 21.371 19.489 0 0
Long Term Debt 23.253 21.371 19.489 0
Other Liabilities, Total 3.664 3.36 3.048 2.903 2.563
Total Equity 191.078 194.847 185.293 176.453 215.96
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.017 0.017 0.017 0.017 0.017
Additional Paid-In Capital 312.323 316.249 320.566 325.779 328.769
Retained Earnings (Accumulated Deficit) 84.068 87.68 82.058 75.862 119.92
Treasury Stock - Common -205.33 -208.195 -216.466 -225.111 -233.164
Total Liabilities & Shareholders’ Equity 259.968 264.242 256.261 253.732 320.165
Total Common Shares Outstanding 13.1455 13.0971 12.9446 12.7914 12.6971
Other Equity, Total -0.904 -0.882 -0.094 0.418
  • Letni
  • Četrtletno
2016 2017 2018 2019 2020 2021
Čisti prihodki/začetna postavka 81.453 51.943 31.903 14.313 11.989 -8.627
Denarna sredstva iz poslovanja 53.207 58.919 52.384 55.986 49.497 28.219
Denarna sredstva iz poslovanja 0.641 0.932 1.155 2.131 0.872 0.764
Amortization 0.948 2.815 2.515 2.52 2.666 2.996
Deferred Taxes -30.116 17.289 -2.468 0.152 -1.511 -3.618
Nedenarne postavke 8.975 15.509 27.168 22.478 34.665 27.167
Cash Taxes Paid 2.8 10.542 2.281 6.673 6.428 10.005
Denarna sredstva Plačane obresti 0.008 0.651 2.084 2.478 2.224 1.197
Spremembe v obratnem kapitalu -8.694 -29.569 -7.889 14.392 0.816 9.537
Denarna sredstva pri naložbenju -45.8 -5.186 -0.133 -0.777 -18.247 -5.323
Kapitalski izdatki -15.84 -5.186 -0.133 -0.777 -0.747 -0.323
Celotne druge postavke denarnih tokov pri naložbenju -29.96 0 0 -17.5 -5
Denarna sredstva pri financiranju -33.67 8.104 -88.117 -24.225 -37.87 -28.392
Postavke denarnega toka pri financiranju -0.286 -1.192 -19.877 -0.524 -1.525 -1.577
Izdaja (odplačilo) delnic, neto -33.384 -39.454 -64.49 -17.701 -31.345 -18.815
Neto sprememba denarnih sredstev -26.263 61.837 -35.866 30.984 -6.62 -5.496
Izdaja (odplačilo) dolga, neto 48.75 -3.75 -6 -5 -8
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -0.421 3.191 -2.431 -8.627 44.058
Cash From Operating Activities 10.478 19.071 20.138 28.219 -16.611
Cash From Operating Activities 0.19 0.378 0.575 0.764 0.177
Amortization 0.706 1.412 2.118 2.996 0.731
Deferred Taxes 0.902 1.119 -2.533 -3.618 -2.432
Non-Cash Items 1.378 10.989 17.689 27.167 6.616
Cash Taxes Paid 0.267 4.3 6.303 10.005 0.041
Cash Interest Paid 0.321 0.625 0.917 1.197 0.265
Changes in Working Capital 7.723 1.982 4.72 9.537 -65.761
Cash From Investing Activities -5.384 -5.269 -5.274 -5.323 -0.168
Capital Expenditures -0.384 -0.269 -0.274 -0.323 -0.168
Other Investing Cash Flow Items, Total -5 -5 -5 -5 0
Cash From Financing Activities -3.02 -8.24 -18.278 -28.392 -11.358
Financing Cash Flow Items -1.551 -1.551 -1.551 -1.577 -1.305
Issuance (Retirement) of Stock, Net 0.531 -2.689 -10.727 -18.815 -8.053
Issuance (Retirement) of Debt, Net -2 -4 -6 -8 -2
Net Change in Cash 2.074 5.562 -3.414 -5.496 -28.137
Ime vlagatelja Vrsta vlagatelja Odstotek neporavnanih obveznosti Delnice v lasti Sprememba delnic Datum imetništva Ocena prometa
BlackRock Institutional Trust Company, N.A. Investment Advisor 12.5072 1627920 -81855 2022-09-30 LOW
Tarriff (Scott L) Individual Investor 11.4696 1492872 -7559 2023-01-23 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 9.5251 1239779 -197535 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 7.3144 952026 -59721 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.9441 773682 3756 2022-09-30 LOW
Brandes Investment Partners, L.P. Investment Advisor 3.5945 467857 3565 2022-09-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 2.7333 355759 38083 2022-09-30 LOW
Acadian Asset Management LLC Investment Advisor/Hedge Fund 2.3911 311220 124347 2022-09-30 MED
Quoniam Asset Management GmbH Investment Advisor/Hedge Fund 2.1943 285611 -8383 2022-09-30 MED
Renaissance Technologies LLC Hedge Fund 2.1073 274279 21300 2022-09-30 HIGH
Adage Capital Management, L.P. Hedge Fund 1.9207 250000 0 2022-09-30 LOW
Smith, Graham & Co. Investment Advisors, L.P. Investment Advisor 1.7765 231222 -799 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.5104 196597 6749 2022-09-30 LOW
Citadel Advisors LLC Hedge Fund 1.4218 185061 119741 2022-09-30 HIGH
JP Morgan Asset Management Investment Advisor 1.3734 178763 -5777 2022-09-30 LOW
Millennium Management LLC Hedge Fund 1.2649 164643 -150096 2022-09-30 HIGH
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 1.251 162832 -39873 2022-09-30 LOW
Allspring Global Investments, LLC Investment Advisor/Hedge Fund 1.1573 150628 62456 2022-12-31 LOW
Morgan Stanley & Co. LLC Research Firm 1.1521 149955 18647 2022-09-30 MED
Charles Schwab Investment Management, Inc. Investment Advisor 1.0996 143124 20630 2022-09-30 LOW

Zakaj izbrati Capital.com? Številke govorijo same zase.

Capital.com Group
+485000+

Borzni posredniki

65000+

Aktivne stranke mesečno

$48000000+

Mesečni obseg naložb

$28000000+

Dvigi vsak mesec

Kalkulator trgovanja

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trgovalna provizija
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Vzvod
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje

Zapiranje

Kratka Dolga

Eagle Pharm Company profile

O družbi Eagle Pharm

Eagle Pharmaceuticals, Inc. je integrirano farmacevtsko podjetje. Družba poskrbi, da se molekula od predkliničnih raziskav do regulativne odobritve in vstopa na trg, vključno z razvojem, proizvodnjo in trženjem. Družba opredeljuje zahtevna terapevtska področja bolezni osrednjega živčnega sistema ali presnovne kritične oskrbe ter onkologije, ki jih je treba zdraviti. Podjetje ponuja tri izdelke: Ryanodex, natrijev dantrolen) (Ryanodex), bendamustin, pripravljen za redčenje (RTD), 500 ml raztopine (Belrapzo), in hitro infundirani bendamustin RTD (Bendeka). Družba trži zdravila Ryanodex in Belrapzo, družba Teva Pharmaceutical Industries Ltd. (Teva) na Japonskem trži bendeko, liofilizirano praškasto obliko bendamustinovega hidroklorida.

Industry: Proprietary & Advanced Pharmaceuticals

50 Tice Boulevard, Suite 315
WOODCLIFF LAKE
NEW JERSEY 07677
US

Izkaz poslovnega izida

  • Annual
  • Quarterly

Ljudje gledajo tudi

Oil - Crude

75.17 Price
+0.660% 1D Chg, %
Nočna pristojbina za nakup -0.0242%
Nočna pristojbina za prodajo 0.0085%
Čas nočne pristojbine 22:00 (UTC)
Razmik 0.03

BTC/USD

22,931.70 Price
-0.100% 1D Chg, %
Nočna pristojbina za nakup -0.0500%
Nočna pristojbina za prodajo 0.0140%
Čas nočne pristojbine 22:00 (UTC)
Razmik 60.00

XRP/USD

0.40 Price
-0.490% 1D Chg, %
Nočna pristojbina za nakup -0.0500%
Nočna pristojbina za prodajo 0.0140%
Čas nočne pristojbine 22:00 (UTC)
Razmik 0.00312

US100

12,490.50 Price
+0.190% 1D Chg, %
Nočna pristojbina za nakup -0.0189%
Nočna pristojbina za prodajo 0.0076%
Čas nočne pristojbine 22:00 (UTC)
Razmik 1.8

Še vedno iščete posrednika, ki mu lahko zaupate?

Pridružite se 485.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com

1. Ustvarite in preverite svoj račun 2. Naredite polog 3. Poiščite svoje trgovanje